fepblue glp 1 coverage Weight Loss Drug from FEHB Plans and Medicare Tier exceptions no longer allowed
Description
Pharmaceutical Journal

It is now known that GLP-1 receptors are widely expressed in the hypothalamus, hindbrain and amygdala with a neuronal link between the periphery and CNS to regulate GLP-1 action (42)

European Teratology Information Services Study (BMJ 2024) Design: Prospective observational cohort Sample: 168 GLP-1 RA-exposed pregnancies, compared with diabetic and obese reference groups Findings: Major birth defect rates: 2.6% (GLP-1 RA) vs
Regular blood glucose monitoring is essential for patients on combination therapy, and dose adjustments of concomitant medications are often necessary

These are fundamentally different drug classes with distinct mechanisms, side effect profiles, and evidence bases

Its available under brand names Wegovy for weight loss and Ozempic or Rybelsus for type 2 diabetes treatment
